The global race toward needle-free drug delivery is accelerating through strategic partnerships between device innovators and pharmaceutical manufacturers.

Innovation is reshaping the needle-free injector landscape, as med-tech companies race to develop devices that are smarter, safer, and easier to use.

Needle-Free Injectors Enter Mainstream as Demand for Pain-Free Delivery Surges

November 2025 – Vienna, Austria — Quinovare is pleased to announce that its leadership team will attend BIO-Europe 2025, taking place from November 3–5, 2025, in Vienna, Austria. The event serves as one of the world’s leading platforms for biopharmaceutical innovation, partnering, and collaboration.

October 2025 – Frankfurt — Quinovare is pleased to announce that its leadership team will be attending the upcoming CPHI Exhibition, taking place from October 28–30, 2025. The event gathers global leaders in the pharmaceutical industry to explore the latest innovations and partnerships shaping the future of healthcare.

Excited to announce that QS Medical (Quinovare) will be joining BIOHK2025 in Hong Kong, September 10–13, at booth T06!